Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2026-01-04 @ 5:33 AM
Study NCT ID:
NCT00674804
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2008-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Communicating a Cancer Diagnosis-Current Methods and Their Effects
Sponsor:
National Institutes of Health Clinical Center (CC)
Organization:
Study Overview
Official Title:
Communicating a Cancer Diagnosis: Current Methods and Their Effects
Status:
COMPLETED
Status Verified Date:
2009-07-16
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will:
* Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer.
* Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed.
* Identify who informs the patient of their diagnosis..
* Determine patient satisfaction with their diagnostic consult.
* Identify indicators of satisfaction with the diagnostic consultation.
Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study.
Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.
* Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer.
* Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed.
* Identify who informs the patient of their diagnosis..
* Determine patient satisfaction with their diagnostic consult.
* Identify indicators of satisfaction with the diagnostic consultation.
Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study.
Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.
Detailed Description:
Background:
\- The goals of the study are to identify how a patient with a diagnosis of cancer is informed of their condition and to illuminate the way in which this information exchange occurs.
Objectives:
To distinguish, identify and determine:
* If the method by which a patient is informed of a diagnosis of cancer is associated with their level of satisfaction with that method of being informed
* Who tells the patient of their condition
* The methods used to inform a patient of their condition
* Prognostic indicators of high satisfaction within the diagnostic consult
Eligibility:
* Patients currently enrolled or being screened for enrollment for a phase I, II or III clinical trial at the National Cancer Institutes clinic center- specifically, within the following branch clinics: Medical Oncology, Metabolism, Surgery and Neuro-Oncology.
* Patient must be 18 years or older and be willing to participate in the study.
Design:
* Primary methodological practice is a self-administered questionnaire.
* Questionnaire to be completed by patient on same day that it is administered at NCI.
\- The goals of the study are to identify how a patient with a diagnosis of cancer is informed of their condition and to illuminate the way in which this information exchange occurs.
Objectives:
To distinguish, identify and determine:
* If the method by which a patient is informed of a diagnosis of cancer is associated with their level of satisfaction with that method of being informed
* Who tells the patient of their condition
* The methods used to inform a patient of their condition
* Prognostic indicators of high satisfaction within the diagnostic consult
Eligibility:
* Patients currently enrolled or being screened for enrollment for a phase I, II or III clinical trial at the National Cancer Institutes clinic center- specifically, within the following branch clinics: Medical Oncology, Metabolism, Surgery and Neuro-Oncology.
* Patient must be 18 years or older and be willing to participate in the study.
Design:
* Primary methodological practice is a self-administered questionnaire.
* Questionnaire to be completed by patient on same day that it is administered at NCI.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 08-CC-0127 | None | None | View |